Louise Boulet - Concepedia

Author

Louise Boulet

Merck Canada Inc. (Canada)

Also Known As

Boulet, Louise, L Boulet, L. Boulet, Louise BOULET, Louise Boulet

Publications

976

Citations

H-Index

Concepts

All Affiliations

Merck Canada Inc. (Canada)McGill University Montreal Neurological Institute and Hospital Jewish General Hospital Merck & Co., Inc., Rahway, NJ, USA (United States)

About

Louise Boulet is an author at Merck Canada Inc. (Canada) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	487
2	Natural Sciences	5	5	305
3	Biochemistry	4	4	275
4	Cell Biology	3	3	54
5	Health Sciences	1	1	78

Louise Boulet

Publications

968

Citations

H-Index

Page 1

	Year	Citations
Distribution and threshold expression of the tRNA(Lys) mutation in skeletal muscle of patients with myoclonic epilepsy and ragged-red fibers (MERRF). Louise Boulet, George Karpati, Eric A. Shoubridge PubMed	1992	334
Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitors Bernard Côté, Louise Boulet, Christine Brideau, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryMedicineNatural SciencesMechanism Of Action	2007	128
Deletion of Microsomal Prostaglandin E2 (PGE2) Synthase-1 Reduces Inducible and Basal PGE2 Production and Alters the Gastric Prostanoid Profile Louise Boulet, Marc Ouellet, Kevin P. Bateman, Journal of Biological Chemistry	2004	118
Localization of phosphodiesterase-4 isoforms in the medulla and nodose ganglion of the squirrel monkey Sonia Lamontagne, Emily Meadows, Pauline Luk, Brain Research Ganglion CellNeurophysiologyNeuroanatomyPhysiologyNeuroendocrine Mechanism	2001	78
Optimization of a Tertiary Alcohol Series of Phosphodiesterase-4 (PDE4) Inhibitors: Structure−Activity Relationship Related to PDE4 Inhibition and Human Ether-a-go-go Related Gene Potassium Channel Binding Affinity Richard W. Friesen, Yves Ducharme, Richard G. Ball, Journal of Medicinal Chemistry Pharmaceutical ScienceDrug TargetPharmacotherapyPotassium ChannelChemical Biology	2003	66
Discovery of disubstituted phenanthrene imidazoles as potent, selective and orally active mPGES-1 inhibitors André Giroux, Louise Boulet, Christine Brideau, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryDisubstituted Phenanthrene ImidazolesBiochemistryMedicineNatural Sciences	2009	61
Discovery of a substituted 8-arylquinoline series of PDE4 inhibitors: Structure–activity relationship, optimization, and identification of a highly potent, well tolerated, PDE4 inhibitor Dwight Macdonald, Anthony Mastracchio, Hélène Perrier, Bioorganic & Medicinal Chemistry Letters Pde4 InhibitorsMedicinal ChemistryNatural SciencesMedicineRational Drug Design	2005	30
Mistranslation in twelve Escherichia coli ribosomal proteins. Cysteine misincorporation at neutral amino acid residues other than tryptophan Michael Laughrea, Jacinthe Latulippe, A.-M. Filion, European Journal of Biochemistry	1987	29
Comparison of inhibition of ovalbumin-induced bronchoconstriction in guinea pigs and in vitro inhibition of tumor necrosis factor-α formation with phosphodiesterase 4 (PDE4) selective inhibitors Eric S. Muise, Ian C. Chute, David Claveau, Biochemical Pharmacology Molecular PharmacologyGuinea PigsLung InflammationOvalbumin-induced BronchoconstrictionMedicine	2002	27
[40] Use of myoblast cultures to study mitochondrial myopathies Eric A. Shoubridge, Timothy Johns, Louise Boulet Methods in enzymology on CD-ROM/Methods in enzymology Mitochondrial MyopathyMitochondrial FunctionMitochondrial DynamicMitochondrial StructureMyoblast Cultures	1996	25

Page 1